Sarah Hawley

1.9k total citations
29 papers, 1.3k citations indexed

About

Sarah Hawley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Sarah Hawley has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Sarah Hawley's work include Prostate Cancer Treatment and Research (12 papers), Ovarian cancer diagnosis and treatment (5 papers) and BRCA gene mutations in cancer (4 papers). Sarah Hawley is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Ovarian cancer diagnosis and treatment (5 papers) and BRCA gene mutations in cancer (4 papers). Sarah Hawley collaborates with scholars based in United States, South Africa and Canada. Sarah Hawley's co-authors include Lawrence D. True, Beatrice S. Knudsen, Robert L. Vessella, Peter S. Nelson, Ruth Etzioni, Ilsa M. Coleman, David Gifford, Paul H. Lange, Daniel W. Lin and Colm Morrissey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sarah Hawley

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Hawley United States 19 542 444 328 254 139 29 1.3k
Antonio Ramos‐Montoya United Kingdom 22 923 1.7× 417 0.9× 428 1.3× 388 1.5× 140 1.0× 38 1.4k
Justin Y. Newberg United States 21 727 1.3× 294 0.7× 352 1.1× 549 2.2× 122 0.9× 55 1.5k
Yi Zhu China 22 609 1.1× 343 0.8× 271 0.8× 125 0.5× 234 1.7× 75 1.2k
Hayley C. Whitaker United Kingdom 22 699 1.3× 510 1.1× 184 0.6× 237 0.9× 118 0.8× 61 1.4k
Kristian Ovaska Finland 13 753 1.4× 335 0.8× 202 0.6× 126 0.5× 206 1.5× 18 1.1k
Nigel Clegg United States 20 1.3k 2.5× 667 1.5× 406 1.2× 370 1.5× 334 2.4× 24 2.2k
Clare Orange United Kingdom 19 618 1.1× 209 0.5× 321 1.0× 428 1.7× 71 0.5× 44 1.2k
Nifang Niu United States 19 728 1.3× 111 0.3× 384 1.2× 205 0.8× 171 1.2× 37 1.2k
Shulin Wu United States 23 670 1.2× 691 1.6× 419 1.3× 342 1.3× 189 1.4× 63 1.6k
Huihui Ye United States 24 641 1.2× 884 2.0× 492 1.5× 398 1.6× 145 1.0× 77 1.8k

Countries citing papers authored by Sarah Hawley

Since Specialization
Citations

This map shows the geographic impact of Sarah Hawley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Hawley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Hawley more than expected).

Fields of papers citing papers by Sarah Hawley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Hawley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Hawley. The network helps show where Sarah Hawley may publish in the future.

Co-authorship network of co-authors of Sarah Hawley

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Hawley. A scholar is included among the top collaborators of Sarah Hawley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Hawley. Sarah Hawley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andersen, M. Robyn, Beth Y. Karlan, Charles W. Drescher, et al.. (2018). False-positive screening events and worry influence decisions about surgery among high-risk women.. Health Psychology. 38(1). 43–52. 3 indexed citations
2.
Haefeli, Jenny, Adam R. Ferguson, Deborah Bingham, et al.. (2017). A data-driven approach for evaluating multi-modal therapy in traumatic brain injury. Scientific Reports. 7(1). 42474–42474. 15 indexed citations
3.
Perito, Emily R., Patrika Tsai, Sarah Hawley, Robert H. Lustig, & Vickie A. Feldstein. (2013). Targeted Hepatic Sonography During Clinic Visits for Detection of Fatty Liver in Overweight Children. Journal of Ultrasound in Medicine. 32(4). 637–643. 4 indexed citations
4.
Drescher, Charles W., Sarah Hawley, Jason D. Thorpe, et al.. (2012). Impact of Screening Test Performance and Cost on Mortality Reduction and Cost-effectiveness of Multimodal Ovarian Cancer Screening. Cancer Prevention Research. 5(8). 1015–1024. 19 indexed citations
5.
Pan, Sheng, Ru Chen, Randall E. Brand, et al.. (2012). Multiplex Targeted Proteomic Assay for Biomarker Detection in Plasma: A Pancreatic Cancer Biomarker Case Study. Journal of Proteome Research. 11(3). 1937–1948. 68 indexed citations
6.
Palmer, Chana, Xiaobo Duan, Sarah Hawley, et al.. (2008). Systematic Evaluation of Candidate Blood Markers for Detecting Ovarian Cancer. PLoS ONE. 3(7). e2633–e2633. 66 indexed citations
7.
True, Lawrence D., et al.. (2008). The androgen‐regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. The Journal of Pathology. 215(2). 118–125. 98 indexed citations
8.
True, Lawrence D., Sarah Hawley, Thomas H. Norwood, et al.. (2008). The accumulation of versican in the nodules of benign prostatic hyperplasia. The Prostate. 69(2). 149–158. 8 indexed citations
9.
Morrissey, Colm, Lawrence D. True, Martine P. Roudier, et al.. (2007). Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clinical & Experimental Metastasis. 25(4). 377–388. 74 indexed citations
10.
Pfitzenmaier, Jesco, William J. Ellis, Sarah Hawley, et al.. (2007). The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: A comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer. Urologic Oncology Seminars and Original Investigations. 25(3). 214–220. 34 indexed citations
11.
Black, Peter C., Gregory J. Mize, Daniel L. Greenberg, et al.. (2007). Overexpression of protease‐activated receptors‐1,‐2, and‐4 (PAR‐1, ‐2, and ‐4) in prostate cancer. The Prostate. 67(7). 743–756. 67 indexed citations
12.
Lin, Daniel W., Ilsa M. Coleman, Sarah Hawley, et al.. (2006). 809: The Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis. The Journal of Urology. 175(4S). 261–262. 1 indexed citations
13.
Hawley, Sarah, et al.. (2006). Combining Results of Microarray Experiments: A Rank Aggregation Approach. Statistical Applications in Genetics and Molecular Biology. 5(1). Article15–Article15. 105 indexed citations
14.
Hawley, Sarah & David R. T. Keeble. (2006). Tilt aftereffect for texture edges is larger than in matched subjective edges, but both are strong adaptors of luminance edges. Journal of Vision. 6(1). 4–4. 10 indexed citations
15.
Pfitzenmaier, Jesco, William J. Ellis, Edward W. Arfman, et al.. (2006). Telomerase activity in disseminated prostate cancer cells. British Journal of Urology. 97(6). 1309–1313. 34 indexed citations
16.
Lin, Daniel W., Ilsa M. Coleman, Sarah Hawley, et al.. (2006). Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis. Journal of Clinical Oncology. 24(23). 3763–3770. 83 indexed citations
17.
Pritchard, Colin C., et al.. (2006). The contributions of normal variation and genetic background to mammalian gene expression. Genome biology. 7(3). R26–R26. 32 indexed citations
18.
Knudsen, Beatrice S., Jared M. Lucas, Ladan Fazli, et al.. (2005). Regulation of Hepatocyte Activator Inhibitor-1 Expression by Androgen and Oncogenic Transformation in the Prostate. American Journal Of Pathology. 167(1). 255–266. 10 indexed citations
19.
Brown, Lisha G., Lawrence D. True, Sarah Hawley, et al.. (2004). Metastases of prostate cancer express estrogen receptor-beta. Urology. 64(4). 814–820. 67 indexed citations
20.
Moore, Stacy, Beatrice S. Knudsen, Lawrence D. True, et al.. (2004). Loss of stearoyl‐CoA desaturase expression is a frequent event in prostate carcinoma. International Journal of Cancer. 114(4). 563–571. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026